What is NDC 51662-1253?

51662-1253 is the product NDC for Flumazenil, Flumazenil .1 mg/mL injection, solution, listed with the FDA by HF Acquisition Co. LLC, DBA Health First. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co. LLC, DBA Health First, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Flumazenil?

20 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Flumazenil NDC 51662-1253 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1253Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1253Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1253-1	5166212530151662125301	10 mL in 1 VIAL, MULTI-DOSE (51662-1253-1)Marketed from Aug 26, 2018
51662-1253-3	5166212530351662125303	10 POUCH in 1 CASE (51662-1253-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1253-2) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Nov 10, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Flumazenil
Generic name (nonproprietary): flumazenil
Active ingredients: Flumazenil — .1 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co. LLC, DBA Health FirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078527
Marketing start: Aug 26, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 51662-1253_101e7ca0-b5a1-f122-e063-6394a90a6649SPL ID 101e7ca0-b5a1-f122-e063-6394a90a6649SPL set ID 744ef484-ef46-8d62-e053-2a91aa0a0c05RxCUI 204508UNII 40P7XK9392
Pharmacologic class: Benzodiazepine Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662125301 followed by a unit qualifier and the quantity

Package 51662-1253-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2024.

Indications (excerpt from the label)

Indications and Usage Adult Patients Flumazenil Injection, USP is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. Pediatric Patients (aged 1 to 17) Flumazenil Injection, USP is indicated for the reversal of conscious sedation induced with benzodiazepines (see Precautions: Pediatric Use ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1253

What is NDC 51662-1253?: 51662-1253 is the product NDC for Flumazenil, Flumazenil .1 mg/mL injection, solution, listed with the FDA by HF Acquisition Co. LLC, DBA Health First. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Flumazenil.
What is the active ingredient?: Flumazenil.
Who is the labeler?: HF Acquisition Co. LLC, DBA Health First, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Flumazenil?: 20 other product NDCs are listed under this name. See all Flumazenil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Flumazenil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1699	51662-1699-03
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9793	00404-9793-05
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9794	00404-9794-10
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1579	51662-1579-03
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co. LLC, DBA HealthFirst	51662-1254	51662-1254-0151662-1254-03
Flumazenil	Flumazenil .1 mg/mL	InjectionIntravenous	Baxter Healthcare Corporation	36000-148	36000-0148-10
Flumazenil	Flumazenil .1 mg/mL	InjectionIntravenous	Baxter Healthcare Corporation	36000-149	36000-0149-10
Flumazenil	Flumazenil .1 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7206	71872-7206-01
Flumazenil	Flumazenil .1 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7321	71872-7321-01
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9683	00143-9683-10

All 21 Flumazenil NDCs

Other NDCs under ANDA 078527

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078527
Product	Strength	Form · route	Labeler	Product NDC
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9683
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9684
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9783
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9784
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9793
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9794
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	A-S Medication Solutions	50090-1337
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co. LLC, DBA HealthFirst	51662-1254
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7008
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7038
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-783
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-784